A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones

(2014) S. A. Smith et al.   JOURNAL OF VIROLOGY

Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics

(2013) Scott A. Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Immature and Mature Dengue Serotype 1 Virus Structures Provide Insight into the Maturation Process

(2013) V. A. Kostyuchenko et al.   JOURNAL OF VIROLOGY

Structural Changes in Dengue Virus When Exposed to a Temperature of 37 C

(2013) G. Fibriansah et al.   JOURNAL OF VIROLOGY

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Dengue structure differs at the temperatures of its human and mosquito hosts

(2013) X. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera

(2012) W. M. P. B. Wahala et al.   JOURNAL OF VIROLOGY

Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop

(2012) J. M. Costin et al.   JOURNAL OF VIROLOGY

Structure of a Dengue Virus Envelope Protein Late-Stage Fusion Intermediate

(2012) D. E. Klein et al.   JOURNAL OF VIROLOGY

Cryo-EM structure of the mature dengue virus at 3.5-Å resolution

(2012) Xiaokang Zhang et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Critical issues in dengue vaccine development

(2011) Stephen J. Thomas et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding

(2011) D. Watterson et al.   JOURNAL OF GENERAL VIROLOGY

Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection

(2011) S. A. Smith et al.   JOURNAL OF VIROLOGY

Features and development ofCoot

(2010) P. Emsley et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

(2010) Martina Beltramello et al.   Cell Host & Microbe

Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2

(2010) S. Sukupolvi-Petty et al.   JOURNAL OF VIROLOGY

Molecular mechanisms involved in the early steps of flavivirus cell entry

(2010) Bärbel Kaufmann et al.   MICROBES AND INFECTION

Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354

(2010) B. Kaufmann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

(2010) Bimmi Shrestha et al.   PLoS Pathogens

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

(2009) W.M.P.B. Wahala et al.   VIROLOGY

Flexible Fitting of Atomic Structures into Electron Microscopy Maps Using Molecular Dynamics

(2008) Leonardo G. Trabuco et al.   STRUCTURE